Nov 06, 2020 / 01:30PM GMT
Operator
Good morning, and thank you all for joining GlycoMimetics Corporate Update Conference Call. (Operator Instructions) I would now like to turn the call over to Ms. Shari Annes of the Investor Relations Group at GlycoMimetics. Please go ahead.
Shari Annes;Investor Relations -
Good morning. Today, we will review our accomplishments and financial results for the third quarter of 2020. We'll also be updating you on several more recent achievements primarily related to emerging data from the Phase III RESET trial evaluating rivipansel in vaso-occlusive crisis in sickle cell disease.
The press release we issued this morning is available on the company's website at www.glycomimetics.com under the Investors tab. This call is being recorded. A dial-in phone replay will be available 24 hours after the close of the call. The webcast replay will also be available in the Investor Relations section of the company's website for 30 days.
Joining me on the call from GlycoMimetics are
Q3 2020 GlycoMimetics Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers